We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Top Buys

1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$2.75M
2
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$2.47M
3
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$2.28M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2M
5
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$1.99M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131K
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$113K
3
VUG icon
Vanguard Growth ETF
VUG
+$104K
4
VT icon
Vanguard Total World Stock ETF
VT
+$103K
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$97.9K

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
351
Unilever
UL
$134B
$8K ﹤0.01%
128
– –
WSBC icon
352
WesBanco
WSBC
$3.92B
$8K ﹤0.01%
182
– –
XYZ
353
Block Inc
XYZ
$47.6B
$8K ﹤0.01%
130
+119
+1,082% +$6.54K
EGRX
354
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$8K ﹤0.01%
100
-300
-75% -$18.9K
ARII
355
DELISTED
American Railcar Industries, Inc.
ARII
$8K ﹤0.01%
200
– –
DDD icon
356
3D Systems Corp
DDD
$439M
$7K ﹤0.01%
500
– –
FNDE icon
357
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.37B
$7K ﹤0.01%
262
– –
FREL icon
358
Fidelity MSCI Real Estate Index ETF
FREL
$1.52B
$7K ﹤0.01%
305
– –
GEN icon
359
Gen Digital
GEN
$16.1B
$7K ﹤0.01%
+360
New +$8.65K
GERN icon
360
Geron
GERN
$924M
$7K ﹤0.01%
2,000
– –
GWW icon
361
W.W. Grainger
GWW
$65.9B
$7K ﹤0.01%
22
– –
JBHT icon
362
JB Hunt Transport Services
JBHT
$27.4B
$7K ﹤0.01%
56
– –
NXPI icon
363
NXP Semiconductors
NXPI
$67.3B
$7K ﹤0.01%
67
– –
WY icon
364
Weyerhaeuser
WY
$17.7B
$7K ﹤0.01%
193
+1
+0.5% +$37
ICPT
365
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$7K ﹤0.01%
+80
New +$5.86K
PETX
366
DELISTED
Aratana Therapeutics, Inc.
PETX
$7K ﹤0.01%
1,665
– –
TSRO
367
DELISTED
TESARO, Inc.
TSRO
$7K ﹤0.01%
164
– –
AXSM icon
368
Axsome Therapeutics
AXSM
$11.8B
$6K ﹤0.01%
+2,000
New +$6.2K
BN icon
369
Brookfield
BN
$107B
$6K ﹤0.01%
443
+23
+5% +$328
CGC
370
Canopy Growth
CGC
$397M
$6K ﹤0.01%
+21
New +$6.36K
CP icon
371
Canadian Pacific Kansas City
CP
$83.2B
$6K ﹤0.01%
160
– –
DTD icon
372
WisdomTree US Total Dividend Fund
DTD
$1.64B
$6K ﹤0.01%
132
– –
EFG icon
373
iShares MSCI EAFE Growth ETF
EFG
$16.4B
$6K ﹤0.01%
82
– –
EWJ icon
374
iShares MSCI Japan ETF
EWJ
$21.5B
$6K ﹤0.01%
110
– –
F icon
375
Ford
F
$56.7B
$6K ﹤0.01%
515
-5
-1% -$57
13 14
15
16 17

Similar funds

VWM
Venturi Wealth Management Austin, Texas $2.22B AUM 24.65% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.23B AUM 15.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.